摘要
建立了同时测定甘草酸单铵盐原料药中主成分18α-甘草酸、18β-甘草酸及其有关物质A、有关物质B含量的高效液相色谱法,并用于其质量标准的建立。采用Durashell C18色谱柱(250mm×4.6mm,5μm),以10mmol/L高氯酸铵(氨水调节pH 8.20)-甲醇(48∶52,v/v)为流动相,流速0.80mL/min,检测波长254nm,柱温50℃,进样量10μL。在优化的色谱条件下,18α-甘草酸、18β-甘草酸、有关物质A、有关物质B在0.50~100mg/L范围内线性关系良好(r>0.999 9),检出限分别为0.15、0.10、0.10、0.15mg/L,平均回收率在97.32%~99.33%之间(n=3),相对标准偏差(RSD)在0.05%~1.06%之间。本方法检测灵敏、重现性好,结果准确可靠,可用于甘草酸单铵盐原料药主成分及有关物质的检测分析,有利于其原料药的质量控制。
An analytical method for tile simultaneous determination of 18a-glycyrrhizic acid, 18fl-glycyrrhizinic acid, related substances A and B and drug quality standard by reversed-phase high performance liquid chromatography (RP-HPLC) was established. The assay was carried out on a Durashell-C,s column (250 mm x4.6 ram, 5 txm) with l0 mmol/L ammonium perchlo- rate (the pH value was adjusted to 8.20 with ammonia ) -methanol (48: 52, v/v) as mobile phase at a flow rate of 0.80 mL/min, and the detection wavelength was set at 254 nm. The col- umn temperature was 50 and the injection volume was l0 pbL. Under the separation condi- tions, the calibration curves of the analytes showed good linearities within the mass concentra- tions of 0.50 - 100 mg/L ( r 〉0. 999 9). The detection limits for 18a-glycyrrhizic acid, 18fl-gly- cyrrhizinic acid, related substances A and B were 0. 15, 0. 10, 0. 10, 0. 15 rag/L, respectively. The average recoveries were between 97.32% and 99.33% ( n = 3 ) with the relative standard deviations (RSDs) between 0.05% and I. 06%. The method is sensitive, reproducible, and the results are accurate and reliable. The method can be used for the determination of principal components and related substances of ammonium glycyrrhizinate for the quality control of rawmaterial drug of ammonium glycyrrhizinate.
出处
《色谱》
CAS
CSCD
北大核心
2013年第9期869-874,共6页
Chinese Journal of Chromatography
基金
河北省自然科学基金项目(H2013201203)
河北省教育厅科学研究计划项目(2009315)
河北省卫生厅医学科学研究重点课题计划项目(20090570)
河北省中医药管理局科研计划课题(2008072)
关键词
反相高效液相色谱法
甘草酸单铵盐
主成分
有关物质
原料药
reversed-phase high performance liquid chromatography (RP-HPLC)
ammoniumglycyrrhizinate
principal component
related substances
raw material drug